Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT04897477 · UNKNOWN
Trial details
- NCT number
- NCT04897477
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2022-04-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.